Provider Resources WA

01/19/24 Health Advisory: Measles Outbreak in Southwest Washington

An active measles outbreak investigation is underway in Clark and Wahkiakum Counties. As of Jan. 10, 2024, investigators have identified 3 lab-confirmed and 3 epidemiologically linked measles cases in unvaccinated adults. Symptoms began in mid-to-late December. All report isolating at home during their contagious period. Investigators have not identified any public exposure locations. Healthcare providers 01/19/24 Health Advisory: Measles Outbreak in Southwest Washington

12/15/23 Health Advisory: Test for tuberculosis people who were incarcerated

TB Skin test

A large outbreak of tuberculosis (TB) in the state prison system may affect more than 800 people who were incarcerated. Requested actions Ask patients about risk factors for TB exposure: Test people with risk factors unless they have a known history of TB infection or TB disease. Evaluate people who test positive to rule out 12/15/23 Health Advisory: Test for tuberculosis people who were incarcerated

09/20/23 Health Advisory: New COVID-19 Vaccines Authorized, Previous Bivalent COVID-19 Vaccines Deauthorized

Syringe in vial

On Sept. 11, 2023, U.S. Food and Drug Administration (FDA) authorized for emergency use new, updated (2023–2024) COVID-19 vaccines from Moderna and Pfizer. FDA deauthorized previous bivalent COVID-19 vaccines. On Sept. 11, 2023, FDA deauthorized previous bivalent COVID-19 vaccines from Moderna and Pfizer. CDC recommends new, updated (2023–2024) COVID-19 vaccines. CDC’s new, updated (2023–2014) COVID-19 09/20/23 Health Advisory: New COVID-19 Vaccines Authorized, Previous Bivalent COVID-19 Vaccines Deauthorized

04/24/23 Health Advisory: Bivalent COVID-19 Vaccine Use Expanded, Monovalent No Longer Authorized

Warning yellow triangle with black exclamation point on left. "Health Advisory" on right.

Requested actions Monovalent Moderna and Pfizer COVID-19 vaccines are no longer authorized for use in the United States. Read below for how to discard and report as waste. Use the new simplified schedule to administer COVID-19 vaccine. People who are 65 years or older or have immune compromise can now get a second bivalent booster 04/24/23 Health Advisory: Bivalent COVID-19 Vaccine Use Expanded, Monovalent No Longer Authorized

03/14/23 Health Advisory: Extensively Drug-Resistant Shigellosis

Pair of hands lathering soap over a steel sink

Requested actions Background Shigellosis is an acute enteric infection. It is an important cause of domestically acquired and travel-associated bacterial diarrhea in the United States. A low infectious dose makes Shigella bacteria easily transmitted from person to person. Consider shigellosis in the differential diagnosis of acute diarrhea, especially in people who: Shigellosis can be a mild, 03/14/23 Health Advisory: Extensively Drug-Resistant Shigellosis

02/03/23 Health Advisory: Multistate Cluster of Antibiotic Resistant Bacteria Associated with Artificial Tears

Warning yellow triangle with black exclamation point on left. "Health Advisory" on right.

Actions requested Background Washington State Department of Health (DOH) and Centers for Disease Control and Prevention (CDC) are investigating a cluster of antibiotic-resistant infections that may be linked to artificial tears. The most frequently reported brand was EzriCare Artificial Tears, a preservative-free product dispensed in muti-dose bottles. These over-the-counter eye drops are sold widely in 02/03/23 Health Advisory: Multistate Cluster of Antibiotic Resistant Bacteria Associated with Artificial Tears

11/08/22 Health Advisory: Increased Respiratory Virus Activity

Multiple viruses are causing increased respiratory illness, especially among children, straining healthcare systems. Transmission of respiratory illnesses is increased in our communities. Schools report much higher absenteeism than normal for this time of year. Our hospital emergency departments are seeing many patients. This increase in illness early in respiratory illness season highlights the importance of 11/08/22 Health Advisory: Increased Respiratory Virus Activity

10/03/22 Health Advisory: Severe cases of monkeypox among people with immune compromise

Warning yellow triangle with black exclamation point on left. "Health Advisory" on right.

Since May 2022, the United States has seen more than 25,000 cases of monkeypox virus (MPV). Most cases are mild to moderate, but some people are at higher risk of severe illness: Under 8 years old. Immune compromise. Atopic dermatitis or eczema. Pregnant. Unsuppressed or uncontrolled human immunodeficiency virus (HIV). Of those currently diagnosed with MPV 10/03/22 Health Advisory: Severe cases of monkeypox among people with immune compromise

09/09/02 Health Advisory: COVID-19 and Monkeypox Update for Providers

Stethoscope on keyboard

COVID-19 On Sept. 1, 2022, Centers for Disease Control and Prevention (CDC) endorsed Advisory Committee on Immunization Practices’ (ACIP’s) recommendation of Moderna and Pfizer COVID-19 vaccine bivalent booster doses. Bivalent booster doses enhance immunity against the ancestral coronavirus strain and protect against newer Omicron variants that account for most current cases. Bivalent booster doses provide optimal protection and 09/09/02 Health Advisory: COVID-19 and Monkeypox Update for Providers

09/02/22 Health Advisory: Bivalent Vaccine Booster for COVID-19

Tray of lab tubes with green and purple tops

Requested actions Be aware: Moderna and Pfizer created bivalent formulations of their mRNA COVID-19 vaccines. The bivalent vaccines target the original strain of SARS-CoV-2 and Omicron subvariants BA.4 and BA.5. United States Food and Drug Administration (FDA) granted emergency use authorization (EUA) to the bivalent vaccines for use as a single booster dose. People can get 09/02/22 Health Advisory: Bivalent Vaccine Booster for COVID-19